1. Home
  2. MWA vs DYN Comparison

MWA vs DYN Comparison

Compare MWA & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MUELLER WATER PRODUCTS

MWA

MUELLER WATER PRODUCTS

HOLD

Current Price

$25.09

Market Cap

3.9B

Sector

Industrials

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$24.57

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MWA
DYN
Founded
1857
1984
Country
United States
United States
Employees
3500
N/A
Industry
Metal Fabrications
Medicinal Chemicals and Botanical Products
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.9B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
MWA
DYN
Price
$25.09
$24.57
Analyst Decision
Buy
Strong Buy
Analyst Count
2
14
Target Price
$30.50
$37.00
AVG Volume (30 Days)
1.2M
2.6M
Earning Date
05-05-2026
05-04-2026
Dividend Yield
1.01%
N/A
EPS Growth
64.86
N/A
EPS
0.65
N/A
Revenue
$1,429,700,000.00
N/A
Revenue This Year
$4.78
N/A
Revenue Next Year
$4.27
N/A
P/E Ratio
$38.28
N/A
Revenue Growth
8.75
N/A
52 Week Low
$22.74
$8.88
52 Week High
$31.00
$25.00

Technical Indicators

Market Signals
Indicator
MWA
DYN
Relative Strength Index (RSI) 46.91 63.30
Support Level $24.81 $16.47
Resistance Level $26.05 $24.52
Average True Range (ATR) 0.58 1.46
MACD 0.01 -0.11
Stochastic Oscillator 35.98 84.68

Price Performance

Historical Comparison
MWA
DYN

About MWA MUELLER WATER PRODUCTS

Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: